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Abstract 
Mammalian development involves a complex system of regulatory signals and reactions 
resulting in highly differentiated cell types with specific structure and function. The liver is a 
major organ that has been studied extensively to understand underlying genetic processes 
responsible for specification, establishment and maintenance of tissue identity. Hepatoma and 
hepatoma variant cell lines have been used as models to understand genetic networks responsible 
for liver function. Whole genome microarray analysis of hepatocyte cell lines has revealed 
candidate genes that may serve as regulators or master regulators of liver specificity. In two 
previous studies in our lab, the role of candidate gene Cellular Repressor of EIA Stimulated 
Gene (CREG 1) in regulation of liver-specific gene expression was determined using transfection 
studies combined with utilization of quantitative real-time polymerase chain reaction (qRTPCR). 
Both studies found strong activation (10-100-fold) of transcription factor Hn/6 and the 
downstream gene Serpinal (a marker gene used to identify liver function). These findings 
suggested that CREG 1 might act through Hnf6 to regulate Serpinal via a Locus Control Region 
(LCR). However, while one study showed that CREG I overexpression in a hepatoma variant cell 
line resulted in modest activation of liver-specific transcription factors Hnfl, Hn/4 and Hnf3, the 
second study suggested robust activation of these genes as measured by qRT-PCR. In the current 
study, a CREG 1 expression vector was reintroduced into one of the variant cell lines (H 11) and 
gene activation profiles monitored to establish validity of the previous studies. However, we 
postulated that CREG-1 overexpression, validated by qRT-PCR, can activate expression of 
hepatocyte transcription factor Hn/6 and the downstream gene Serpinal along with other liver­
specific downstream genes. Results showed that CREGl can fully rescue expression of liver-
iv 
specific genes including transactivation genes, suggesting its role as a master regulator of liver 
function. CREG l action appears to act at least partially through HNF6 gene activation, as well as 
through activation of HNF4/HNF1 pathway, both of which act to increase expression of the 
serpin locus through LCR activation through HNF6. 
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The mammalian liver plays a critical role in the human digestive system. As with all 
mammalian organ development, a complex array of regulatory signals and responses are 
involved, which are dependent on positive and negative regulation. These signals drive 
establishment of cell specialization through transcriptional regulation, and regulation of tissue 
specific gene expression is controlled by trans-acting factors interacting with cis-acting elements 
within DNA sequences (2). Still the mechanisms of tissue differentiation are not clear. To 
understand genetic processes which are required for specification, establishment and 
maintenance of tissue identity, extensive studies have been done. One model with which to study 
cellular differentiation is the mammalian hepatocyte and/or hepatoma cells. Large numbers of 
liver enriched genes have been characterized- some of which are controlled by common 
regulatory pathways, and others are controlled by characterized master regulators. 
1.1. Liver Development 
As an essential organ in the human digestive system, the mammalian liver has important 
role in endocrine and exocrine functions. These functions include detoxification, metabolism 
(36), glycogen storage, secretion of digestive fluids, maintenance of homeostasis (39), regulation 
of cholesterol synthesis and transport, metabolism of urea and secretion of plasma proteins such 
as apo-lipoproteins and albumin. Liver diseases such as hepatic fibrosis, cirrhosis, hepatitis and 
hepatocellular carcinoma (HCC) are characterized by loss of liver function and are associated 
with high mortality rates ( 40). The liver is composed of various differentiated cell types: 
hepatocytes, cholangiocytes (bile duct epithelial cells), Kupffer cells (liver resident 
macrophages), hepatic stellate cells, and sinusoidal endothelium and pit cells (natural killer cells) 
(31 ). Each cell type has specific functions during proliferation and regeneration of the liver after 
hepatectomy and injury. 
Multiple stages are involved in liver development. An array of genes is expressed by the 
liver in order to control metabolism and catabolism, with processes ranging from enzymatic to 
hematopoetic components, driven by liver enriched transcription factors (TFs) (31 ). The most 
common markers for liver identity include albumin, transthyretin and a-fetoprotein (37), each 
of which is controlled by liver-enriched TFs. For example, the promotor region of the albumin 
gene binds transcription factors Forkhead Box Protein A (FoxA) and GAT A4. This binding 
results in the opening of chromatin to allow binding of Hepatocyte Nuclear Factor la (HNFla) 
and CCAAT-enhancer binding protein p(C/EBPP) to initiate transcription of the albumin gene 
(37). However, FoxA2 gene expression must first be activated by expression of Hepatocyte 
Nuclear Factor- IP (HNF IP) in early embryonic development, and impairment of this activation 
step results in absence of hepatic specification due to lack of competence by endodermal cells 
(37). Hormonal factors are also required for interaction of intercellular and matrix-cellular 
proteins, and are essential for liver ontology which starts at embryonic day 9 in the mouse (22). 
The earliest events in the initiation of liver generation depend on interaction of cardiogenic 
mesoderm and foregut endoderrn, which initiates differentiation, as in tissue recombination 
experiments (12, 22). Also required is the interaction of cardiogenic growth factor (FGF) and 
bone-morphogenic proteins (BMP2 and BMP4), produced by cardiogenic mesoderm and septum 
transversum respectively (37). 
Competent endoderm cells then respond to fibroblast growth factor (FGF) produced by 
cardiogenic mesoderm cooperating with bone-morphogenic proteins (BMP2 and BMP4) 
produced by the septum transversum, resulting in expression of hepatic genes (37). 
2 
An inductive signal is introduced generating liver bud formation, which is then 
transduced to liver primodium ( 1 2, 22). Interkinetic nuclear migration, proliferation and 
differentiation of hepatoblasts and expression of homeobox factors Hex and GATA-6 are 
induced by that signal (3 7). 
To generate a functional liver, a process of maturation occurs in cells, which include 
physiologic functions and morphologic changes, exclusively dependent on precise control and 
co-ordination of genetic networks. Furthermore, during embryogenesis a dynamic transcriptional 
network is involved. This network helps establish regulatory loops (cross regulatory and auto 
regulatory), with the help of liver enriched transcription factors (37). This phenomenon is 
observed by in vivo analysis of DNA -protein interactions that shows the complex and myriad of 
interactions of cis-acting hepatocyte-specific DNA regulatory regions (21 ). Tissue specific 
expression of hepatic and pancreatic regulation is dependent on liver-specific TFs (26). 
Critical proteins involved in liver identity include HNF-la (a homeodomain protein), HNF-1 p, 
HNF3P!FoxA2 (a winged helix factor), HNF-4a.l (an orphan nuclear receptor), HNF-
6/0NECUTl (a member of one cut homeodomain protein) and LRH-1 ( 42, 26, 37) and CCAAT 
enhancer binding protein (C/EBP) (37), are essential for phenotypic character for liver and 
tightly regulated by TFs. 
Gene-regulatory regions cooperatively work with cofactors for stimulating transcription 
of common targets. However, liver-specific TFs are interdependent and important for basic 
functioning of liver tissue (26). Biochemical functions such as gluconeogenesis, regulation of 
carbohydrate synthesis and storage, detoxification and synthesis of serum proteins, complement 
factors and coagulation factors (26). HNFI a has a partial role in hepatic phenotype maintenance, 
acts through promoters of more than 222 different liver specific genes (26). Moreover, 
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involvement of HNFI � in transcriptional regulation of genes responsible for bile acid sensing 
and fatty acid oxidation (37). 
Along with HNFl, HNF3WFoxA2 controls the regulation of hepatic function as it has 
overlapping DNA binding properties (37). Similarly, liver receptor homolog-1 (LRH-1) is 
associated with a nuclear hormone receptor family, that has control over bile acid and cholesterol 
metabolism (37). 
Along with these, Hepatocyte Nuclear Factor 4a (HNF4a) has a significant impact on the 
liver phenotype. In hepatocytes, HNF4a has been shown to bind to 1262 genes (26). HNF4a is 
essential for transcriptional regulation as it binds to RNA polymerase II, a process which has 
been confirmed by transcriptome analysis (26). Dysfunction of HNF4al or HNFla leads to 
maturity onset diabetes of the young (MODY), which indicates problems in glucose metabolism. 
HNF6binds to 227 hepatocyte genes and 189 genes in pancreatic islet cell(26). It also mediates 
the effects of growth hormone, inhibits glucocorticoid activity, and stimulates expression of 
genes in the gluconeogenic, glycolytic and bile acid synthesis pathways (37). Also, HNF6 is 
required for hepatocyte proliferation and feed forward loop switch (26). Hepatic transcriptional 
regulation is dependent on the synergistic association among HNFla, HNF4al and HNF6 (26). 
Developmental and metabolic functions in hepatocytes are regulated by these HNF's genes that 
encode transcription factors and cofactors (17). From transcriptional studies it is known that 
HNFla and HNF4al create a multicomponent loop which forms a bi-stable system to switch 
between two alternate states and establish a feedback control mechanism, as they occupy each 
other's promoters in hepatocytes (17). 
Therefore, maintenance of terminal phenotype of hepatocytes is dependent on several 
HNF's - HNF6, HNFla and HNF4al, which form multi-input motifs. Binding of these HNF's 
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plays a vital role in regulation and the tissue specific expression of the downstream genes (26). 
Finally, development, differentiation and homeostasis are controlled by transcription regulators 
through tissue specific gene expression, ensuring the simultaneous repression of unnecessary and 
conflicting genes (32). 
1.2. Cell Culture Model Systems 
Different techniques are used to study live gene hierarchies. One of the techniques is cell 
fusion. In cell fusion techniques, two distinct and highly differentiated cell types such as 
hepatoma cells and fibroblast cells are fused to generate somatic cell hybrids. These cannot 
express liver specific genes in a process known as extinction (4). This extinction process can 
sometimes be reversed if chromosomes from one of the parents are lost during cell division. In 
most cases fibroblast chromosomes are lost ( 4). Though tissue specific genes do not express, 
housekeeping genes of both the cell types are expressed. 
Another method is used to develop variants, which are particularly used to understand the 
driving force of liver identity, particularly mutant hepatocytes identification (9). Variants have 
multiple genetic or epigenetic lesions which turns in de-differentiation. To reveal the effects of 
HNFs in hepatocytes such as - activation and transcriptional regulation of downstream genes, it 
is essential to observe screening of these variants and expression profile (24). These studies have 
impact over understanding the mechanism of HNFs - how they react in regulatory pathways 
when there is a defect and how they act while maintaining the liver phenotype (13). The rescue 
of the liver phenotype in hepatoma variant cells has revealed the understanding of liver genetics. 
Both positive and negative selection strategies were considered to get hepatoma variants from rat 
hepatoma cells, which are different in morphology and liver specific gene expression (9). Studies 
s 
show that variants do not express HNF4 and HNFlcx genes ( 1 3). Ectopic expressions of HNF4 
and/or HNFl cx  rescue each other as well as downstream liver genes. This study suggests that its 
important in  transcriptional regulation of hierarchical pathways (9). 
In the current project, dedifferentiated cells are generated from the original rat tumor cell 
line H4IIEC3. This hepatoma cell line is the parent cell line of Fg14 cells, which is derived by 
selection against integrated trangsgenes expressing adenosine phosphoribosyl transferase 
(APRT) and hypoxanthine phosphoribosyl transferase (HPRT/GPT) under control of the liver 
specific human SERPINAJ (aka alpha-I antitrypsin) promoter. 
Transfected cells were selected by growth in media containing drugs inhibiting the de 
novo nucleotide biosynthesis and require nucleotide precursors that can be utilized by transgene 
expression: adenine-aminopetrin-thymidine (AAT) for SERPINAJ-aprt expression and 
hypoxanthine-aminopetrin-thymidine (HAT) for SERPINAJ-gpt expression (Fig. 1). 
Hepatoma variant cell lines (Fig. I )  were generated by negative selection, using toxic analogs-
2.6-diaminopurine (DAP) and 6-thioxanthine (6-TX). The surviving cells lack APRT and HPRT 
enzyme production as well as lack expression of the endogenous Serpinal gene (9, 1 3, 17). 
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Fig.1. Derivation of the hepatoma variant cell lines. Fgl4 cells contain two selectable trans­
genes - adenine-aminopterin-thymidine (AAT) and hypoxanthine-aminopetrin-thymidine (HAT) 
under the control of the liver-specific human SERPINAJ gene promoter. Selection against - 2,4-
diaminopurine(DAP) and 6-thioxanthine (6TX), expression of these genes resulted in the 
isolation of hepatoma variant cell lines (e.g. HS2, M38, H l  1 and M 29) which lack expression of 
several liver genes. (APRT- Adenine phosphoribosyJ transferase; OPT- Guanosine 
phosphoribosyl transferase). 
1.3. Serpinal Gene Regulation as A Model for Liver Gene Regulation 
The SERPINAJ gene is highly conserved in the liver has been studiedto understand the 
molecular mechanism of transcriptional regulation in this organ (9) For example, gene silencing 
in hepatoma variants cell lines has been shown to be due to loss of trans-acting factors HNF 1 a 
andHNF4a. 
In this current study, the hepatoma variant cell lines Hl l ,  M29, M38 and HS2 are 
deficient in HNF4a /HNF a transactivation pathway, which results in the loss of expression of 
many liver specific downstream genes including SERPINAJ. 
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SERPINAJ is a member of serine-proteinase inhibitor SERPIN super family (45). It is an 
abundantly produced circulating protease inhibitor, encoded by a single gene on the long arm of 
human chromosome 14 (23). In 1955, Schultze isolated these highly polymorphic 55 kda serum 
glycoproteins. They occur in the alpha-I globulin fraction ( 45) and have ability to inhibit the 
destructive neutrophil-secreted protease, elastase, and cathepsin G ( 19). SERP !NA J is principally 
synthesized (70-80 %) in liver cells (45) but also produced by pulmonary alveolar cells, 
macrophages, monocytes and intestinal epithelial cells (19, 45). The SERPINAJ half-life is 3-5 
days with normal plasma concentration ranging from 0.9-1.75 g/L. Auto- regulation of 
SERPINAJ was observed when exposed to a SERPINAJ-elastase complex or elastase alone. 
Also, SERPINAJ was shown to be synthesized de novo in human cancer cells (45). 
Through in-situ hybridization studies, it has been shown that hepatocytes and hepatoma 
cell lines synthesize SERPINAJ in ample amounts in cell culture (19). SERPINAJ is an ideal 
model to study tissue specific gene expression and extinction because of the following 
characteristics: (i) liver enriched trans-acting factors HNFl a and HNF4 binding site at the 
proximal promoter of SERPINAI has been well characterized; (ii) in hepatoma x fibroblast 
hybrids, SERPINAJ gene expression is reduced by> 1000 fold; (iii) the genes encoding HNFla 
and HNF4 are highly characterized and (iv) tissue specific expression of a gene can be obtained 
by utilization of only the 5' proximal promoter of the SERPINA 1 gene (13). The expression of 
the SERP !NA 1 gene is regulated synergisticalJy by hepatocyte nuclear factor-I a (HNFl a) and 
HNF4 ( 19). Mutations in the SERPINAJ promoter region prevent binding of HNFla and reduce 
cellular expression (24). Previous studies have shown that ectopic expression of trans-acting 
elements results in chromatin remodeling around the Serpinal locus, suggesting that a single 
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transcription factor can change the chromatin structure of DNA and rescue of hepatic expression 
in hepatoma variants (14). 
1.4. DNA Microarray Analysis 
The DNA microarray, a tool initially developed in -1987, provides a high throughput 
data platform with which to analyze gene expression of most or all genes within a cell type or 
tissue. This technique provides whole gene expression profiling (i.e. the quantitative data of an 
expression level of thousands of genes simultaneously under different conditions). For example, 
the expression pattern of the same gene under different times and conditions can be monitored to 
elucidate the role of a given gene in genetic pathways ( 15, 18). The process of gene clustering is 
based upon regulatory pathways or disease association. Various methods that have been used for 
analysis, including hierarchical clustering, k-means, partitions around memoids (PAM a.ka K­
memoids), self-organizing maps (SOM), mixed model-based clustering and tight clustering (33). 
DNA microarrays have become highly utilized to determine differential gene expression patterns 
or to compare the differences in mRNA expression between similar cells subjected to different 
stimuli or between developmental stages or different cellular phenotypes. 
Analysis of expression arrays is based upon successful implementation, development and 
normalization of fluorescent signals which is broadly divided into three different stages: (I) array 
fabrication (II) probe preparation and hybridization and (Ill) data collection, normalization and 
analysis (15). The methods of target-sample preparation generally include generation of the 
first-strand of cDNAs from RNA that are labelled or tagged with a capture sequence, or by 
generating antisense RNA (aRNA) via an in-vitro transcription reaction (18). 
A common type of microarray chip is constructed on a derivatized glass microscope slides by 
arraying PCR amplified cDNA clones or genes at high density. Expression sequence tags (ESTs) 
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are extensively used for the gene identification, gene discovery and mapping in human and other 
organism, which are single pass partial sequences of cDNA clones. Representative unique 
transcripts of cDNA clones are then selected for analyses. The cDNA clone inserts from 
cultured cells are typically amplified by PCR using universal amplification primers. Products are 
then purified for the efficient binding of the amplified clone inserts onto the microscopic slide. A 
high speed robotic system is then used to print or coat the amplified PCR product suspended in a 
high-salt denaturing buffer and applied to poly-L-lysine or aminosilane-coated glass microscopic 
slides. RNA from different sources is typically labelled with fluorescent dyes such as Cy3- or 
Cy5- dUTP for co-hybridization experiments. The microscopic slide is pre-hybridized with 
washing buffer for removal of unbound DNA impurities and then hybridized with the labelled 
probe. Differential gene expression level is measured by using a confocal laser scanner, capable 
of distinguishing signals generated between Cy3 and Cy5 labeled probes. An image is generated 
and processed based upon the identifying and distinguishing arrayed genes against spurious 
signal, estimation of background signal and the background -subtracted hybridized intensities. 
The generated data is normalized by adjusting the differences in labeling and detection 
efficiencies of fluorescent labels and quantity of the starting RNA between the assayed samples 
(15). Finally, data is analyzed and difference in expression level is determined based upon the 
cut-off value of specific threshold levels. 
1.5. Project Overview and Goals 
In order to elucidate the pathways for normal regular liver function in hepatoma variant 
cells, whole genome expression profiling approach was carried out in this laboratory in order to 
identify the liver specific genes that are responsible for activation or repression of gene 
1 0  
expression. Four variant cell lines (M29, HS2, H l  1, and M38), were tested against the parental 
hepatoma cell line Fg14. Whole genome microarray experiments were conducted using the RNA 
isolated from parental and variant cell lines. The experiment was performed in triplicate for 
reproducibility and viability and tested by comparing against the biological replicates for each 
cell line and gene variability within the microarray. 
A total of -22,500 target genes were analyzed. Based upon the generated data two criteria 
were implemented when comparing the gene expression between the parental hepatoma cell and 
the hepatoma variants: (i) a > 5-fold signal variability difference within replicates of parental 
against variant cell lines and (ii) at least two of the four variant cell lines tested must show these 
> 5-fold differences in expression. This led to the identification of 355 repressed genes, 132 of 
which were common in all of them. Also, 213 genes were found to be activated among the 
variant cell lines, although only two genes were activated in all four variant cell lines, as shown 
in the Fig. 2. Further analysis was done to identify those repressed/activated genes that are either 
transcription factors or encode products that play a known role in signaling pathways. It was 
hypothesized that at least some of these genes are regulated by liver specific master regulators 
such as HNFla, HNF3p (FOXA2), HNF4 and HNF6 (ONECUTI). From the pool of these 
genes, candidate genes were identified using two criteria: (i) a > 5 fold increase or decrease in 
expression in 2 of 4 variants compare to parental Fg14 cells and (ii) a known role in 
transcriptional activation or interaction with transcriptional activation pathways. Based upon the 
criteria, 14 repressed genes (Table 1) and 7 activated genes (Table 2) were identified as 
potentially having a capacity to contribute in maintaining the liver (hepatic) phenotype (Fig. 3). 
These preliminary data suggest that a high level of reprogramming has occurred in variant cells, 
1 1  
leading to activation of few sub-sets of genes along with loss of liver-specific gene expression 
(47). 
> S·folciRepr=ed 
M38 Hll M38 Hll 
HS2 M29 
Fig. 2. Gene repressed and activated in hepatoma variants cells using Illumina whole genome rat 
rnicroarray. A total of 355 genes were identified the cut-off value of > 5 folds repression 
compared to Fgl4 levels, 132 genes were shared in repressed in all four variant cell lines 
whereas only 2 genes are activated by > 5 fold in all 4 variant cell lines. 
Table.I. List of candidate genes identified from list of repressed genes. 
Fold Repression Gene name Description 
M38 HS2 Hll M29 
6.2 I. 7 3.6 5.5 BHLBH2 Basic helix-loop-helix domain containing Class 2B 
12.9 15.0 14.6 13.7 CREB3L3 cAMP responsive element binding protein 3-like 3 
3.6 6.4 2.7 5.9 CREG EI A-stimulated gene (predicted) 
17.4 18.7 18.7 16.7 DPPA4 Developmental pluripotency associated 4 (LOC680293) 
(predicted) 
12.2 11.9 11.9 IO.I DPPA5 Similar to DPPA5developmental pluripotency associated 5 
(RGD 1564306( (predicted) 
9.3 8.5 7.9 8.8 GAS2 Growth arrest-specific 2 (RGDl 562167) (predicted) 
5.1 6.0 2.8 5.8 HHEX Hemtopoietically-expressed homeobox protein 
118.6 128.0 131.9 107.4 IGFBPl Insulin like growth factor binding protein I 
8.3 9.6 0.1 7.4 MDK Midkine (neurite growth-promoting factor 2) 
10.7 5.3 14.9 16.9 ONECUTI One cut homeobox 1 
7.0 14.9 2.1 43.3 RNF125 Ring Finger protein 125 (predicted) 
9.4 10.3 10.6 5.3 SECI6b SECl6 homolog B (S. cerevisiae homolog) 











9.5 1.0 21.0 TCFAP2B Transcription factor Ap-2 beta 
Table. 2. List of candidate genes identified from list of activated genes. 
Fold Activation 






0.6 I.I  
4.1 0.9 
Gene name Description 
M29 
6.2 TIMPI TIMP metallopeptidase inhibitor I 
6.3 BMP7 Bone morphogenetic protein 7 
8.8 GPRl77 G protein-coupled receptor 177 
27.1 PITXI Paired-like homeodomain I 
9.0 IGFBP7 Insulin-like growth factor binding protein 7 
11.5 WIFI Wnt inhibitory factor I 








Fig. 3. Candidate gene predicted to involve in regulation of liver phenotype. 
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Cellular repressor of EIA stimulated gene-1 (CREGI) is one such candidate gene 
identified through microarray analysis that falls under the repressed category. Our hypothesis 
was that CREG I plays a role in maintaining the hepatic phenotype through activation of liver 
specific transcription factors and may therefore partially revert a non-hepatic cell type to hepatic 
phenotype. In this study, we are presuming that CREG I plays a vital role in regulating 
transcription factors and signaling proteins that play a significant role in the tissue-specific gene 
activation in hepatoma variant cell. This will shed light upon the role of CREG I on liver specific 
gene regulation. To this end, CREG 1 will be introduced into Hl 1 bepatoma variant cells and 
transfectants screened for reactivation of liver gene expression. The specific goals of this work 
include I) Validation of tissue specific liver gene expression in hepatoma variant cell line HI I 
by reverse transcriptase quantitative Polymerase Chain Reaction (RT-qPCR), 2) Identification of 
liver-specific transcription factors whose expression is affected by CREG 1 3) Determination of 
the level of up-regulation or down-regulation of the downstream liver genes by CREG 1 and 4) 
Comparison and validation of RT-qPCR data with microarray data. The overall goal of this 
project is to use whole genome functional data to understand the putative molecular role of 
CREG I in liver function. 
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Hepatoma Variant Cells 
Whal• G•n•l• Miuoarray 
I 
Identification of Candidate Genes 
I 
Repressed (e.c. CREG1) 
I 
Transfect H11 cells 
I 
Generation and selection of G418 resistance clones 
M . ,. I . on1tor tver cene repression 
qRT-PCR 
Fig.4. Flowchart showing the schematic representation of the strategy to be implemented to 
study the effects of CREG 1 in hepatoma variants (Hl 1 ). 
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2.1. Cell Culture 
Chapter 2 
Materials and Methods 
All cells were maintained in a medium containing 1 : 1  Ham's F1 2/Du1becco's modified 
Eagle's medium (FDV) containing 10% fetal bovine serum (FBS) (GIBCO BRL) and 5 µg/100 
ml penicillin-streptomycin (GIBCO) at 37° C in a humid 5% C02 water-jacketed incubator. All 
cells were derived from the parental cell line H4IIEC3, a rat tumor. The rat hepatoma variant cell 
line H I  1 was derived from Fg-14 cells by negative selection against Aprt (adenine 
phosphoribosyltransferase) and Gpt (xanthine - guanine phosphoribosyltransferase) transgene. 
H l l cells were generated from Fg-14 cells by using 20 µg/ml of2, 6-diaminopurine (DAP) and 
30 µg/ml 6-thioxanthine in the culture medium. Surviving clones were picked using cloning 
rings and each clone was expanded. 
2.2. Cell Transf ection 
Semi-confluent cell plates were used for the transfection of candidate genes. FDV (0.5 
ml) media without penicillin and streptomycin was added to a microfuge tube. DNA (1 µg/l µl) 
along with 5 µl Lipofectamine Plus reagent (Invitrogen, Inc) was added and mixed gently for 
five minutes at room temperature. Then, 5 µl of Lipofectamine L TX reagent was added and 
mixed gently by pipetting and incubated for 30 min at room temperature. 
Media on cell plates was removed by pipetting. The transfection mixture prepared in the 
microfuge tubes were added in the wells of the plates and incubated at 37° C in 5% C02 
incubator for 6 - 8 hrs, rocking periodically. After 6 - 8 hrs, medium was replaced with FDV 
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containing 1 0% fetal bovine serum plus penicillin and streptomycin and incubated for 2 days at 
37° C in 5% C02 incubator changing media after 18-24 hrs. For stable transfection, cells were 
split 1 : 1 0 into complete medium containing 500 µg/ml G41 8  and incubated for 2-3 weeks. G41 8  
resistant clones were either picked individually or pooled and expanded so that RNA could be 
extracted. 
2.3. RNA Isolation 
RNA was extracted from confluent cell lines using a RNeasy Mini Kit (Qiagen, Cat 
#741 04) following the RN easy Mini kit Protocol (Qiagen, Cat#79254), with a DNase-I step 
modification. Nutrient medium was removed from the culture dish, and cells were lysed by 
treating with highly denaturing guanidine isothiocyanate (GITC) containing RL T buffer and P­
mercaptoethanol. Cells were then scraped from the dishes and homogenized by applying the cell 
mixture to Qia-shredder columns placed in a collection tube followed by centrifugation. The 
flow-through was treated with 70% ethanol which was then applied to resin filter within the 
RNeasy column in a collection tube. The resin filter was washed with R WI buffer followed by 
digestion with DNase I for 15  min at room temperature and centrifuged. The filter was again 
washed with RWI, and then washed with RPE buffer twice followed by quick centrifugation 
after each wash. After the purification process, RNA was eluted from resin filter by applying 40 
µL RNase-free water into the column followed by centrifugation at 1 0,000 x g for 60 sec. All 
RNA samples were collected in microfuge tubes and stored at -70° C. Concentration and purity 
of the RNA was determined by using a nano-drop spectrometry at 260 and 280 nm. 
2.4. Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
17 
Complementary DNA (cDNA) was synthesized from purified RNA by using a four-step 
RT-PCR protocol and the MasterAmp High Fidelity RT-PCR kit (Applied Biosystem, part# 
4368814, Lot#09 l l I 00). A final volume of 50 µl of reaction mixture contained 3 µl of RNA 
template (5 ng-10 ng), 19 µl of sterile nuclease free water, 25 µJ of Master Amp 2X RT-PCR 
PreMix, 2 µl of 25 pmoles of oligo (dT), and I µl (50 U) of Moloney Murine Leukemia Virus 
Reverse Transcriptase (MMLV-RT) Plus. The reaction mixture was incubated at 37° C for 30 
min. The Bio-rad Thermal Cycler was used to synthesize cDNA. The first step was carried at 25° 
C for 10 min, followed by second step at 37° C for 2 hrs, then third step at 85° C for 5 min and 
finally, fourth step at 4° C for infinity. Newly synthesized cDNA was stored at -20° C, to be used 
for the quantitative polymerase chain reaction (qPCR). 
2.5. Quantitative-Polymerase Chain Reaction (qPCR) 
All the cDNA samples were diluted and concentration (5 ng/µl) was standardized among 
the samples. A final volume of 20 µl of reaction mixture contained 2 µI of cDNA template (5 
ng/µl), 6.75 µl of sterile nuclease free water, 10 µl of Fast SYBR® Green Master Mix (Applied 
Biosystem) and 1.25 µI of gene specific primer (0.5 µM) (IDTDNA). The applied Biosystem 
thermocycler was used to measure the expression of mRNA level. The first step was carried at 
95° C for 3 sec, followed by extension/annealing step at 5° C above melting temperature (Tm) 
for 30 sec. A final melt curve step was performed at 95° C for 15 sec down to 60° C for 60 sec 
and a final step at 95° C for 15 sec. The control for RT-qPCR contains 8.75 µl of sterile nuclease 
free water, 10 µl of Fast SYBR® Green Master Mix (Applied Biosystem) and 1.25 µl of gene 
specific primer (0.5 µM) (IDTDNA). The list of primers used for genes and their Tm is given in 
the Table 3. The cDNA quality was tested against the reference gene Gapdh. Duplicate assay 
was performed for each cell line and reaction was repeated three times. 
18 
Raw threshold (Ct) value was averaged after the amplification for each of the cell line. 
The amplified target genes in each hepatoma and hepatoma variant were normalized to the 
respective Gapdh Ct-value, generating a delta-Ct value (6Ct). Fold differences in gene 
expression were determined with a delta delta-Ct (66Ct) calculation. The 6Ct of the control cell 
line (Fgl4) was subtracted from the hepatoma variant 6Ct value, generating a 66Ct value. Using 
a log base 2 scale, the calculated difference was placed into the 66Ct equation: 2(6Ct (sample -
experimental) - (6Ct Control). 
2.6. Statistical Analysis 
Statistical significance was determined by student t-test assuming unequal vanance. 
Significance value was accepted at p < 0.05 level. 
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Table 3. Primers used in the quantitative Polymerase Chain Reaction (qPCR), primer sequences, 
melting temperature and annealing temperature of primers:. 
Primer Primer Sequence Tm Annealing 
(°C) temperature 
(oC) 
HNF6 F-5' CAGTGGCTCT AAGCACAGT AA 3' 54.5 6 0  
R-5' CAGTGTGGTGGAACAGAT AAGA 3' 54.3 
HNFl F-5' CCA TIC TGA AAG AGC TGG AGA AC3' 57.l 60 
R-5' AGG TAC GAC TTG ACC A TC TTT GC3' 55.6 
HNF4 F-5' TGG CAO AAC TCC ATC CGT CAT TC3' 56.6 6 0  
R-5' AAC TGG ATC TGC TCG ATC ATC TG3' 56.5 
SERPINAl F-5' CCTATACCGGGAGCTGGTCCAT 3' 60.3 64 
R-5' TTGCGAGTGTCACCCTTGCT 3' 59.5 
SERPINA3n F-5' ACT GGG AGA GGA CAC TCT ATT3' 54.5 60 
R-5' GTA GAG GCT GAA GGC AAA GT3' 54.7 
SERPINA3m F-5' CCC ACA TGG ACC AAG AAG AA3' 54.7 64 
R-5' GTG CCC AGA GGA AGG AAA TAG3' 55. l  
SERPINA4 F-5' GAC CTG AGC CCA GAT GTA AAG3' 55.1 64 
R-5' ACT GGT AGA GAC TCT GGA AGA A3' 54.4 
SERPINA6 F-5' AAC CAG CAT GTC AAG GAT AAG A3' 54. l 6 0  
R-5' GCC TCT GAG GAA GAT GTA GTT G3' 54.8 
SERPINAlO F-5' GGA ACT TTG CCT CTA CCT TTG A3' 54.8 64 
R-5' GGT CAC CCG A TT TCT CCA T AA G3' 55.1 
SERPINAl l F-5' ACA AAG TCA CAC CCA CCA TTA3' 54.2 64 
R-5' GAA GAG GAT GTT CCC TGG TAT TT3' 54.4 
ALB F- 5' CATCCTGAACCGTCTGTGTG 3' 55.7 6 0  
R-5' TTTCCACCAAAGACCCACT A 3 '  55.8 
rKNGl(l) F- 5' AACACAA TTGCCGCCTTCTCACAG 3' 60.2 64 
R-5' GTGCAATGGAATGACCAAGTGCCT 3' 60.2 
rFGBl (4) F-5' AAGGAGACAAGGTGAAGGCACACT 3' 60.3 64 
R-5' AAGAACATGCCGTTGTGGATGCTC 3' 59.9 
rPCKl (2) F- 5' CGCTATGCGGCCCTTCTTT 3' 58. 3 60 
R-5' CGTGAAAGATCTTGGGCAACT 3' 57.5 
rHHEXl (4) F-5' AGGTGCCTCTTTGGACAGTTCTCA 3' 60.l 64 
R-5' AGCCTTTATCACCCTCGATGTCCA 3' 59.8 
rGAPDH F-5' TGA TTCTACCCACGGCAAGTT 3' 56.5 60 
R-5' TGA TGGGTTTCCCA TTGATGA 3' 54.2 
rCREGl (3) F-5' CATCAGACACCCTGAGATGAAA 3' 54.4 6 0  




To understand the loss of liver cell function, it is essential to observe the hierarchy of 
signaling pathways. Hepatoma variant cell lines were derived from parent hepatoma cell lines 
and selected according to their inability to activate an introduced SERP INAJ-Aprt transgene in 
parental cell line Fg14. Hepatoma variants were generated at a frequency < i o-6 from the Fgl 4  
parent (47). The hepatic phenotype o f  variant cells was strongly repressed in the hepatoma 
variant cell lines including loss of expression of the chromosomal Serpinal gene; also found was 
the repression of trans-acting factors and loss of transgene expression controlled by the 
SERPINAJ promoter. To identify the defects in regulatory pathway, variant cells were found to 
lack expression of liver enriched transcription factors, hepatocyte nuclear factors Hnfl a and 
Hnf 4 (9) as well as many downstream liver-specific genes. 
3.1. Part A. CREGl as a candidate for liver gene activation 
3.1.1. Stable transfection of the CREGl gene in the Hll  variant cell line 
Based upon RatRef-12vl Expression Bead Chips (Illumina, Inc., San Diego, CA) whole 
genome microarrays, it was predicted that Cellular repressor of E I  A-stimulated gene- I 
(CREG I), a putative candidate gene, may have role in activating liver-specific genes and 
transcription factors. Microarray data showed that in each of four hepatoma variant cell lines, 
CREG 1 expression was repressed from 3 to 7 folds compared to hepatoma cells. Unexpectedly 
RA Tl fibroblast cells also abundantly expressed this protein (Table 4). A similar comparison 
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was done for other known liver-enriched genes, including C/ebpa, HnD, Hnfla, Hnf4 and Hnf6. 
Microarray results showed that each of the transcription factors, with the exception of HNF3, 
was substantially reduced in the hepatoma variant cell lines ((Table 5). 
Based on the above results, we asked whether reintroduction of CREG 1 would partially 
restore the liver phenotype in the hepatoma variant cell line H 1 1 .  Previous data showed 
reactivation of approximately 25% of repressed hepatic upon forced over-expression of the 
HNF l a  gene in the H l  1 cells (47) . 
To this end, H l  1 cells were stably transfected with an exogenous CREGl gene, which 
was incorporated in cell genome, for studying CREG 1 's role in hepatoma cells. Plasmid vector 
pCMV6-Kan/Neo (Fig. 5), is introduced in H l  1 cells. This vector expresses CREG 1 containing 
the selectable neo marker gene providing geneticin ( G418) resistance. In this plasmid, a strong 
enhancer/promoter from the cytomegalovirus (CMV) 
(http://wwv. .origene.com/cdna/111ouseclones. 111spx) controls CREG I gene expression. Variant cells 
were transfected, followed by splitting after 2 days under G4 l 8 selective pressure resuting in 
several G4 I 8-resistant clones . After 2-3 weeks, these clones were picked individually and or 
pooled (Table 6) and expanded for RNA extraction. Transfection efficiencies were observed by 
parallel transfections with a plasmid expressing the green fluorescence protein (GFP) reporter 
(results not shown). After a few rounds of transfections, a total of 21  H l  1-CREGl clones were 
picked individually and 4 pools of clones were generated (70 to 1 50 clones/pool). For a negative 
transfection control, FDV media without plasmid was used in the transfection procedure and 
resulted on no G41 8  resistant clones. A total of 1 2  of the individual clones were analyzed and 2 
of 4 pooled samples were analyzed for over-expression of CREG I (Table 6). The introduced 
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CREGI transgene expression was monitored by qRT-PCR for reactivaion of hepatocyte nuclear 
factors and downstream liver genes (see below). 
3.1.2. Overexpression effects of CREGl on transcription factor expression 
In the genome, transcription factors act as an activators or repressors of genes. In human 
hepatocytes, four master transcription factors HNFla, HNF3P (FOXA2), HNF4a and HNF6 
(ONECUTl )  have been identified (26). These HNFs operate synergistically to regulate liver 
gene expression (26), which has been confirmed through previous studies of microarray analysis 
data (47). Also, they bind to 800-4000 gene promoters in chromatin immunopreciptation (ChIP) 
assays. 
Expression levels of several of these HNFs was measured by qRT-PCR. Results from the 
pooled clones showed that forced expression of CREG 1 in the H 1 1  variant cells resulted in 
robust (1 00-fold) activation of both Hnfl a and Hn/4 to levels similar to those observed in the 
parental Fg14 cells (Fig. 7). Hnf3 levels were also monitored. These levels were found to be 
similar between the Fgl4 and H I  1 variant cells original. As expected, these levels were similar 
for the Hl  1 -CREG pool as well (Fig. 8). Likewise, Hn/6 was also dramatically activated (30-
35 folds) in the pooled Hl 1 -CREG cells and showed variable activation in the four clones tested 
(Clones 7, 12, 1 7  and 20) ranging from 6-fold to 18-fold compared to the H I  I parental cells. 
(Fig. 9). Levels in some of the clones (clones 7 and 12) were similar to those of the Fg14 
hepatoma cells. 
3.1.3. CREGl overexpression effects on downstream genes 
Regulation of downstream genes in distinct cell types depends largely upon 
transcriptional control. Previous studies have also shown that regulation and/or activation of liver 
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specific downstream genes requires binding of hepatocyte nuclear factors and co-activators to 
promoter regions. Because CREG 1 is a putative transcription factor (predicted based upon 
published data, 47), we asked if CREGI could activate liver specific downstream genes. 
We first monitored expression of �hree key liver markers, Alb, Pckl and Hhex l .  Results 
show that each of these marker genes is strongly activated (up to 20-fold) in the CREGl ­
overexpressing H 1 1  cells (Fig. 10) to levels just below those of the parental F g 14  hepatoma cell 
line (Fig. 9). We next tested two additional liver gene markers, Kngl and Fgb l ,  both of which 
were also strongly activated (Fig. 1 1  ). 
3.1.4. CREGl overexpression effects on SerpinA genes Cluster 
It was first asked that whether CREG I could activate expression of liver genes. The 
cellular repressor of EIA- stimulated gene-I (CRE G l )  plays an important role in mammalian 
cells. It is a secreted protein that could be a regulator of many aspects of early development ( 16). 
Quantitation of RNA levels using qRT-PCR amplification of cDNA generated from RNA. 
Expression of the SerpinAl gene was tested in the HI  1 - CREGl cells. Serpinal was strongly 
activated (150 folds) compared to the H l  1 cells (Fig. 12). These results were compared to the 
differences in expression found between FG 14 and H 1 1  cells using whole genome microarrays. 
Microarray analysis showed SerpinAl expression to be expressed 55- fold higher in the FG14 
cells compared to the Hl 1 cells (Table 5). 
Next we asked whether other members of the rat Serpin locus were rescued by the 
introduction of CREG 1 into the H 1 1  cells. We first examined microarray data which showed that 
expression of several serpin locus genes repressed in the HI  1 cells compared to the FG14 
parental cells. Serpina3n, 4 and 6 showed the most obvious expression differences, with the other 
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serpin genes showing near background levels (-100 units) of expression in the FG 14 cells. 
However, it was reported previously that the rnicroarray data lacks sensitivity to monitor gene 
expression compared to qPCR (47). 
We monitored gene expression for several serpin locus genes using qPCR. Nearly all (6 
of 7) of the serpin locus genes tested showed a dramatic reduction of expression in the hl  1 cells 
compared to the FG 14  parental cells (Fig. 13) .  These results suggest that the microarray was 
unable to detect differential expression for many of the lower- expressed serpin genes. 
Importantly, the H l  1 - CREGl cells showed strong rescue of nearly all serpin genes tested. In 
most of the cases, H 1 1 -CREG 1 cells expressed levels or serpin genes higher than the FG 14 cells. 
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Table 4. Comparison of expression levels of CREG 1 hepatoma variant cells lines 
compared to parental Fgl4 hepatom cells as determined by by microarray analysis. Raw 
fluorescent values are shown for FG 1 4  and RAT I cells. Ratios of gene expression of the 
variant cells compared to the parental F g 14 cells are shown for the four variant cells lines 
M38, HS2, H I  1 and M29. 
Gene RATl Fg14 RAT1/Fg14 Fg14/M38 Fg14/HS2 Fg14/H l l  Fg14/M29 
CREG 1 4885 2791 2 3 7. 6 6 
Table 5. Expression levels of transcription factors in hepatoma and hepatoma 
variant cell lines as determined by microarray data. 
Transcription Average values Fold Exl!ression 
factors Fg14 H l l  M38 H l l  HS2 M29 
Cebpa 250.0 100.7 2.1 2.5 1 .5 2.1 
Hnf3 (FoxA2) 3417.9 5632.0 0.6 0.6 1 . 1  1 . 1  
Hnfla 455.2 107.7 3.4 4.2 4.5 4.2 
Hnf4 247.0 88.6 2.9 2.8 2.9 2.7 
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Fig. 5. True Mouse Clone Vector pCMV6-Kan/Neo. The CMV promoter and a Kozak 
consensus sequence drive protein expression in mammalian cells. An antibiotic selection cassette 
(Kanr/ Neo� confers resistance to kanamycin in E. coli and neomycin analogs (G4 1 8) in 
mammalian cells. The T7 promoter upstream of the ORF allows protein expression in cell-free 
system. Each clone contains a fully verified insert sequence 
(http: /v.,,n\ .origene.com/cdna/mouseclones.mspx). 
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Fig. 6. Expression of transfected mouse CREG l in transfected hepatoma variant H l  1 cells. 
CREG I is overexpressed in individual clones (H 1 1-CREG 1-Clone7, H 1 1 -CREG 1 -Clone20) and 
pooled clones (HI 1-CREGI -Pool) as detected by qR-TPCR. Fold differences compared to the 
parental HI  I cells is shown. All samples were measured in triplicate by qRT-PCR reactions 
Values are normalized for RNA quality using Gapdh expression values for each specific cell 




















CREGl effects on Hnfl & Hnf4 expression 
1 1  
Hll FG14 
Cell lines 
• HNFl • HNF4 
H 11-CREG Pool 
Fig. 7. CREGI activates Hnfl and Hnf4 in the HI 1 cells. CREGl overexpression resulted in 
activation of liver- specific HNF transcription factors. Fold differences compared to the parental 
H l l  cells is shown. All samples were measured in triplicate by qRT-PCR reactions Values are 





























H 11-CREG Pool 
Fig. 8. CREGI overexpression effects in transfected HI I cells. Fold differences compared to the 
parental Hl 1 cells is shown. All samples were measured in triplicate by qRT-PCR reactions 
Values are normalized for RNA quality using Gapdh expression values for each specific cell 
lines. 
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Fig. 9. CREG 1 activates Hnf6 in the Hl  1 cells. Pooled clones and individual clones were 
monitored for Hnf6 expression. Fold differences compared to the parental H l  I cells is shown. 
All samples were measured in triplicate by qRT-PCR reactions Values are normalized for RNA 
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CREGl effects on downstream gene expression 
RHHEXl 
T 
I • •  
ALB 
Downstream genes 
• Hll • FG14 • Hll-CREG Pool 
PCKl 
I 
Fig. 10. CREG l activates liver downstream hepatic genes in the H l l  cells. Downstream genes, 
required for cellular maintenance, proliferation and differentiation, were tested in the H l  1 -
CREG l cells. Liver-specific genes Hhex l ,  Pckl, and Alb were activated by CREG. Fold 
differences compared to the parental H l  1 cells is shown. All samples were measured in triplicate 
by qRT-PCR reactions Values are normalized for RNA quality using Gapdh expression values 
for each specific cell lines. 
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• Hll • FG14 • Hll-CREG Pool 
Fig. 11 .  Downstream genes required for cellular maintenance, proliferation and differentiation 
were tested in the H l  1 -CREGJ cells. Liver-specific genes, including Kngl and Fgbl ,  were 
strongly activated. All values are normalized for RNA quality using Gapdh expression values for 






































Fig. 12. CREGI activates SerpinAl expression in the Hl  1 cells Downstream gene Serpinal ( a  
liver phenotypic biomarker) was strongly activated. All samples were measured in triplicate by 
qRT-PCR reactions Values are normalized for RNA quality using Gapdh expression values for 
each specific cell lines. 
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Fig. 13. CREG 1 over-expression activates serpin cluster genes in transfected H l  1 cells. Fold 
activation for Serpin3A and Serpin3 (Top) and SerpinA4 and Serpin A6 (Bottom) are shown. All 
samples were measured in triplicate by qRT-PCR reactions Values are normalized for RNA 




Regulation of gene expression in mammals involves both activation and repression of 
tissue-specific genes which dictate tissue function and phenotype. Hepatoma variants are derived 
from rat liver tumor cells, but lack liver gene expression. These variant cells lines were 
generated using a selection scheme. In these variants,hundreds of liver specific genes have been 
stably silenced, including those encoding tissue specific transcription factors (47). In this study, 
through whole genome microarray analysis, cell specific transcription factors and genes 
responsible for cell signaling, activated or repressed in the system, were identified. One 
candidate gene - CREG 1 (repressed) was identified as candidate genes in at-least two out of the 
four hepatoma variant cells (M29, HS2, H l  1, M38) tested via microarray analysis comparing 
expression levels to those of the parental Fg 14 hepatoma cells ( 42). 
4. CREG 1 As A Candidate for Liver Gene Activation 
Though the underlying pathways disrupted in the variant cell lines which result in loss of 
liver gene expression have yet to be elucidated, these cell lines have been used to identify the 
role of liver-specific transcription factors in driving phenotype. In this study, the dedifferentiated 
hepatoma variant HI  I cells were used. These have been shown to be defective in expression of 
Hnfl a and Hnf4, along with other downstream genes (Bulla et al, 2010). Stable introduction of a 
CREG 1 expression plasmid into the H l  1 cells was found to reactivate many liver-specific 
transcription factors and downstream genes. 
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Cellular repression of EIA stimulated genes-I (CREG 1 ), a secretory glycoprotein, was 
first discovered while screening a cDNA library of a model organism -Drosophila melanogaster 
(fruit fly). The screening was for proteins that interact with transcription factors (43). It has been 
expressed ubiquitously in differentiated tissues; not being restricted to a single type of cell ( 43). 
In humans, CREGI is located on chromosome l q24.2 (shorter arm of chromosome!) .  The 
CREG 1 gene is 12.8 kb in size and composed of four exons and introns ( 44). The transcriptional 
product of CREG 1 is 220 amino acids ( 16), which is a conserved protein, shares a similar 
sequence with the EIA protein of adenovirus known to regulate the repression and activation of 
genes via E2F. E2F is the gene that codes families of transcription factors (16). CREG I ,  resides 
at the perinuclear region i.e. cytoplasmic area that surrounds the nucleus. An extensive study 
revealed that it regulates transcription via RNA polymerase II promoter i.e. it is a transcription 
factor binding complex ( 16). Furthermore, this complex can antagonize transcriptional activation 
and adenovirus mediated cellular transformation, which is dependent on interaction of insulin 
like growth factor receptor 2 (IGF2R) ( 48). Through gene card analysis, it is known that CREG 1 
has the ability to bind to Transcription factor TBP and tumor suppressor, Rb. 
The ability of CREG 1 to bind the general transcriptional factor TBP and tumor 
suppressor, Rb is also suggested by Gene Card analysis (http://www.genecards.org/cgi­
bin/carddisp.pl?gene=CREG I &search=4 1 d1 78bt28c87c08d7ecfab386a9cf9c#pathways source). 
The gene ontology database (http://amigo.geneontology.org/amigo/gene product/RGD: 1 3 06804) 
has suggested CREG 1 to be a member of a transcription factor binding - transcription factor 
complex that has the ability to regulate gene transcription. 
CREG 1 has not previously been reported to play a role in liver development or 
maintenace of liver-specific gene expression, and it is unclear how liver function is activated by 
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CREG I in the current study. Previous studies revealed that hepatocyte nuclear factors (HNFs) 
function synergistically by forming a complex of inter-dependent signaling meshwork (27, 42). 
Also, transcriptional regulation in liver is known to be controlled by DNA binding proteins and 
co-activators (26). 
This study found that HNF6 was found to be dramatically activated (>25 fold) in both 
single clone and pooled HI I clones overexpressing CREG 1 from an introduced expression 
plasmid. HNF6 is considered a major transcription factor in mammalian development ( 40). In a 
mouse model, if HNF6 is not present during development, there occur abnormalities in 
intrahepatic and extrahepatic bile ducts, defects in gallbladder formation. This observation 
suggests that HNF6 is essential for development of biliary and gall bladder (27, 28).HNF6 has a 
single domain that binds to DNA and has sequence homology between ONECUT (HNF6) 
families and functional redundancy, can regulate the nuclear localization and transcription 
activation and homeodomain motif (21). Studies in zebrafish suggests that Hnfl P regulates Hnf6 
(25). Though in current study, influence of CREG 1 overexpression on Hnfl p expression was 
not tested. 
HNF6 regulates transcriptional activity via binding the proximal region sequence of the 
RNA polymerase I I  core promoter, as it has DNA binding motif, which is revealed by UniProt 
data (http://www.uniprot.org/uniprot/09UBCO) analysis. Furthermore, HNF6 binding sites can 
be found in the promoter or enhancer regions in many of the liver specific downstream genes 
(28). Also, an HNF6-C/EBP transcription complex is involved in this independent transcription 
process via synergy, without involvement of any other hepatocyte transcription factors (30). To 
express the HNF6 targeted genes, it is required to recruit CBP co-activator protein. TBP (7), 
C/EBP ( 1 1 )  and TFIID (I 0) are transcriptional components which work as cofactor or co 
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activator of transcriptional control regulatory machinery. From gene card analysis it is 
understood that CREG 1 regulates transcription through these transcription components. 
Interestingly, it is unclear as there is no direct link between HNFs and CREG 1 .  One 
possibility is that CREG 1 has a cofactor binding region- FMN (Flavin mono- nucleotide), which 
is responsible for interaction with other proteins (perhaps HNF6) through protruding extended 
loop (29, 46). Secondly, it has a secretory property, which can either easily enter the membrane 
or accumulate on extracellular space and cell surface. If this assumption is true, CREG l could 
regulate morphogenesis, cellular differentiation and transcriptional modulation (20). This could 
result in stabilization of cellular identity and regulate a myriad of biological functions through 
receptor interaction like IGF2R, protein- protein adhesion and cell communication (35). 
Serpinal (45), Hex], Alb, Wnt4 (40) are liver specific downstream genes, all of which 
were acrtivated the H 1 1 -CREG I cells, are expressed during early stages of liver development. 
However, other liver enriched transcription factors have been identified that regulate these. 
Traditionally the liver specific gene is SERPINAI has been used as as phenotypic marker for 
liver function. SERPINAI gene mutations result in emphysema or liver disease (45). HNFl and 
HNF4 have been shown to bind to promoter region for expressing SERPINAl (2). The current 
studies suggest that CREG 1 strongly activates SERPINA 1 gene, though there was no activation 
of Hn/4 or Hnfl genes (which are strongly down- regulated in the hepatoma variant cells) (47). 
This leads to assumption that there might be a common co-activator/co-factor binding site in 
SERPINAI promoter. Two types of interactions are predicted: 1 )  An interaction between HNF6 
and SERPINAl mediated via an alternative protein-RNA interaction domain in SERPINAl and 
2) an indirect effect mediated via protein-protein interaction between SERPINAl and an 
unknown RNA binding protein. However, there is no evidence that protein - protein interaction 
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may affect transcriptional regulation of Serpinal gene. One study suggests that expression of 
Serpinal gene cluster of five genes can be controlled by locus control region (LCR) (citation). 
However, recruitment of liver specific transcription factor- HNF6a, HNF3p, C/EBP-a. and -P 
activates as well as RNA polymerase II responsible for activating gene through serpin LCR (34). 
Therefore, it is possible that over-expression of SERPINA I is responsible for synergistic 
association of HNFs with CREG I .  It might be that expression of SERPINAl increases when 
CREG I binds or CREG 1 regulates the expression of Serpina I gene in an independent fashion. 
Hematopoietically expressed homeobox (HHex) is homeobox transcription factor which 
ts regulated by Wnt4 signaling in conjunction with SOX13 by dissociating the P-catenin/TCFl 
complex (38, 42). Also, lack of HNF4a. interaction with LEFI (P-catenin regulated protein) leads 
to repression of Wnt4 expression ( 40). In the current study, Hhex expression was affected in the 
Hl 1 cells over-expressing CREGI, suggesting that the observed expression might have some 
impact over the pathway. 
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Future Directions 
We have identified the cellular repressor of E 1 A-stimulated gene (CREG 1) through 
whole genome analysis of hepatoma and hepatoma variant cells as a candidate master regulator. 
We asked whether the ability of CREGI for rescuing expression of both liver maker gene 
SerpinAl and several liver- specific transcription factors (HNF6, HNF4 and HNFl )  suggested its 
role as a master regulator of liver function. The fact that CREG 1 also rescued most genes of the 
Serpin locus suggests that the LCR was activated. The overexpression of Serpin genes by 
CREG 1 could be the result of CREG 1 binding to Serpin promoters. This could be determined 
through the use of software that predicts transcription factor binding sites (TFBS) paired with 
functional assays like ChlP to detect the binding site sequences of CREG 1 on promoters. 
Likewise, genome- wide binding sites for HNF6, which has not been reported in vitro, could be 
predicted using prediction software. Since, it is unclear whether HNF6 is required for this 
activation, gene knockdown experiments using siRNA could be used to reduce HNF6 expression 
in the H 1 1- CREG 1 cells and determine if SerpinA 1 expression is affected. Also, knocking down 
of HNFl and HNF4 expression may clarify whether CREG 1 can activate Serpin locus 
expression independent or other liver transcription factors. 
Finally, it may be necessary to determine how CREG 1 might function in development and 
maintenance of liver tissue. The use of other cell culture model systems as well monitoring 
CREG 1 expression during embryogenesis in normal and CREG 1 knockout mice model could 
help clarify the role of the protein in liver function. It would also be useful to conduct whole­
genome microarray analysis on the H l  1 - CREGI cells compared to FG14 cell and H l l  cells to 
identify the extent of genomic remodeling that has occurred due to over expression of CREG 1 .  
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